Our assumption is also supported by the fact that, compared to naïve controls, a significant increase in the number of striatal c-Fos+ nuclei consequent to L-DOPA administration was evident in PD-D mice, although this increase was more pronounced in PD mice. This evidence concerns the gene FOS and Parkinson disease.